Health
Nanobodies that neutralize SARS-CoV-2 – EurekAlert
Two separate studies have identified nanobodies – which could be produced less expensively than monoclonal antibodies – that bind tightly to the SARS-CoV-2 spike…
Two separate studies have identified nanobodies – which could be produced less expensively than monoclonal antibodies – that bind tightly to the SARS-CoV-2 spike protein and efficiently neutralize SARS-CoV-2 in cells. “The combined stability, potency, and diverse epitope engagement of our … nanobodies … provide a unique potential prophylactic and therapeutic strategy to limit the continued toll of the COVID-19 pandemic,” write authors on one paper (Michael Schoof et al.) In the battle against…
-
Noosa News18 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News19 hours agoMotorcyclist dies in crash with truck
-
Noosa News20 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Business24 hours ago5 things to watch on the ASX 200 on Thursday 20 November 2025
